Apremilast
You are here: Home » Products » API » Rheumatic Diseases And Immune Drugs » Apremilast » Apremilast

loading

Apremilast

CAS No.:608141-41-9
Formula:C22H24N2O7S
Type:Pharmaceutical API
Appearance:Powder
Certificate:GMP, COPP, WC, DMF
Shelf Life:2 years
Quality Standard:CP, EP, JP, USP
Assay:98.0%-102.0%
Chemical Name:N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-1,3-dioxoisoindol-4-yl] acetamide
Availability:
Quantity:
facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button


Apremilast  is a member of the class of isoindoles that is isoindole-1,3-dione  substituted at position 4 by an acetamido group and at position 1 by a 1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl group. Used for treatment of psoriatic arthritis. It has a role as a phosphodiesterase IV inhibitor and a non-steroidal anti-inflammatory drug. It is an aromatic ether, a N-acetylarylamine, a sulfone and a member of phthalimides. Apremilast, also known as Otezla, is a phosphodiesterase 4 (PDE4) inhibitor used to treat various types of symptoms resulting from certain inflammatory autoimmune diseases. It belongs to the same drug class as [Roflumilast] and [Crisaborole].


Function


1.Inhibition of PDE-4: PDE-4 is an enzyme that breaks down cyclic adenosine monophosphate (cAMP) within cells. cAMP is a signaling molecule involved in various cellular processes, including immune and inflammatory responses. By inhibiting PDE-4, Apremilast increases the levels of cAMP in certain immune cells, leading to downregulation of pro-inflammatory mediators and cytokines. This helps to dampen the exaggerated immune response and reduce inflammation.

2.Treatment of Psoriasis: Psoriasis is an autoimmune skin condition characterized by the rapid buildup of skin cells, leading to the formation of thick, red, and scaly patches on the skin. Apremilast can help improve psoriasis by targeting the underlying immune and inflammatory processes that contribute to the disease. By reducing inflammation, it helps to alleviate the symptoms and slow down the excessive skin cell growth.

3.Treatment of Psoriatic Arthritis: Psoriatic arthritis is a form of inflammatory arthritis that can occur in people with psoriasis. It affects the joints, causing pain, swelling, and stiffness. Apremilast can help manage psoriatic arthritis by modulating the immune response and reducing inflammation in the affected joints.

4.Treatment of Behçet's Disease: Behçet's disease is a rare autoimmune disorder that causes inflammation in multiple parts of the body, including the mouth, skin, eyes, genitals, and joints. Apremilast is also used to treat the oral ulcers associated with Behçet's disease by reducing inflammation.


Package


1kg/bag or 3kg/bag or according to customer’s requirements.




Related News

content is empty!

Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.

QUICK LINKS

PRODUCT CATEGORY

Copyright © 2023 Shandong Loncom Pharmaceutical Co., Ltd. All Rights Reserved. Sitemap | Privacy Policy
Supported by leadong.com
Contact Us